46 related articles for article (PubMed ID: 16803475)
1. Metastasis of ovarian cancer to nasal skin and skin on the trunk: a rare case report.
Chen C; Yingyao O; Yan X; Qianru H; Hong W; Chen C; Lei Y
Front Oncol; 2023; 13():1266820. PubMed ID: 37920167
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases from Ovarian Carcinoma: An Evaluation of Prognostic Factors and Treatment.
Wohl A; Kimchi G; Korach J; Perri T; Zach L; Zibly Z; Harel R; Nissim U; Spiegelmann R; Nass D; Cohen ZR
Neurol India; 2019; 67(6):1431-1436. PubMed ID: 31857529
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor status predicts development of brain metastases in ovarian cancers.
Mittica G; Senetta R; Scotto G; Aglietta M; Maggiorotto F; Ghisoni E; Genta S; Boldorini R; Manini C; Morra I; Buosi R; Sapino A; Cassoni P; Valabrega G
Oncotarget; 2017 Jun; 8(25):41143-41153. PubMed ID: 28467804
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery for brain metastasis from gynecological malignancies.
Kasper E; Ippen F; Wong E; Uhlmann E; Floyd S; Mahadevan A
Oncol Lett; 2017 Mar; 13(3):1525-1528. PubMed ID: 28454285
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review.
Hacker NF; Rao A
Gynecol Oncol Res Pract; 2016; 3():7. PubMed ID: 27330821
[TBL] [Abstract][Full Text] [Related]
6. Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature.
Gressel GM; Lundsberg LS; Altwerger G; Katchi T; Azodi M; Schwartz PE; Ratner ES; Damast S
Int J Gynecol Cancer; 2015 Nov; 25(9):1711-6. PubMed ID: 26332394
[TBL] [Abstract][Full Text] [Related]
7. Late isolated central nervous system relapse from ovarian serous adenocarcinoma: a case report and literature review.
de Castria TB; Rodrigues SR; Diz Mdel P
Case Rep Obstet Gynecol; 2014; 2014():297307. PubMed ID: 25506007
[TBL] [Abstract][Full Text] [Related]
8. Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant
Malecki M; Dahlke J; Haig M; Wohlwend L; Malecki R
J Genet Syndr Gene Ther; 2013 Jul; 4(6):152. PubMed ID: 24587967
[TBL] [Abstract][Full Text] [Related]
9. Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site.
Ma MW; Qian M; Lackaye DJ; Berman RS; Shapiro RL; Pavlick AC; Golfinos JG; Parker EC; Darvishian F; Hernando E; Shao Y; Osman I
Neuro Oncol; 2012 Jul; 14(7):849-58. PubMed ID: 22561799
[TBL] [Abstract][Full Text] [Related]
10. Brain metastases from ovarian carcinoma.
Piura E; Piura B
ISRN Oncol; 2011; 2011():527453. PubMed ID: 22191058
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.
Matsuo K; Eno ML; Ahn EH; Shahzad MM; Im DD; Rosenshein NB; Sood AK
Am J Clin Oncol; 2011 Oct; 34(5):488-93. PubMed ID: 20921883
[TBL] [Abstract][Full Text] [Related]
12. Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases.
Hoffmann J; Fichtner I; Lemm M; Lienau P; Hess-Stumpp H; Rotgeri A; Hofmann B; Klar U
Neuro Oncol; 2009 Apr; 11(2):158-66. PubMed ID: 18780814
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer.
van der Burg ME; Onstenk W; Boere IA; Look M; Ottevanger PB; de Gooyer D; Kerkhofs LG; Valster FA; Ruit JB; van Reisen AG; Goey SH; van der Torren AM; ten Bokkel Huinink D; Kok TC; Verweij J; van Doorn HC
Eur J Cancer; 2014 Oct; 50(15):2592-601. PubMed ID: 25096168
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
15. Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Fountzilas G; Aravantinos G; Kalofonos HP; Efstathiou E; Salamalekis E; Farmakis D; Skarlos D; Briasoulis E; Economopoulos T; Dimopoulos MA
Gynecol Oncol; 2005 May; 97(2):436-41. PubMed ID: 15863142
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Pectasides D; Aravantinos G; Fountzilas G; Kalofonos C; Efstathiou E; Karina M; Pavlidis N; Farmakis D; Economopoulos T; Dimopoulos MA
Anticancer Res; 2005; 25(5):3553-8. PubMed ID: 16101179
[TBL] [Abstract][Full Text] [Related]
17. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
18. Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy.
Kastritis E; Efstathiou E; Gika D; Bozas G; Koutsoukou V; Papadimitriou C; Pissakas G; Dimopoulos MA; Bamias A
Int J Gynecol Cancer; 2006; 16(3):994-9. PubMed ID: 16803475
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
